Factors Affecting Medication Adherence and the Success of Pulmonary Tuberculosis Therapy in Several Community Health Centers in Ambon City

Authors

  • Surtia Surtia Universitas 17 Agustus 1945, Jakarta, Indonesia
  • Sylvia Rizky Prima Universitas 17 Agustus 1945, Jakarta, Indonesia

DOI:

https://doi.org/10.58344/locus.v4i9.4713

Keywords:

compliance, pulmonary tuberculosis, Education, knowledge, access to health facilities, family support, health worker support, success

Abstract

This study examines the Factors Affecting Medication Adherence and the Success of Pulmonary Tuberculosis Therapy in Several Community Health Centers in Ambon City. Tuberculosis (TB) remains an infectious disease and a global health challenge, including in Indonesia. The success of TB therapy is highly dependent on the patient's adherence to the prescribed treatment. This study aims to analyze the factors that affect the adherence of pulmonary TB patients and their relationship with therapy success. The study design is observational with a cross-sectional approach, conducted both retrospectively and prospectively on pulmonary TB patients at several health centers in Ambon City. Data were collected through questionnaires and patient medical records. A sample of 150 respondents was selected using the purposive sampling method. The analysis was performed using the chi-square test and logistic regression. The results showed that family support, health worker support, and access to health facilities had a significant effect on patient compliance. Meanwhile, education and knowledge did not have a significant influence. The analysis also indicated a significant relationship between medication adherence and therapy success. Family support emerged as the most dominant factor influencing adherence. These findings highlight the importance of a holistic approach in TB management, particularly by strengthening social support and primary health services. Recommendations include increasing the educational role of pharmacists and implementing regular compliance monitoring. Further research is suggested to conduct longitudinal studies and explore psychosocial and cultural factors.

References

Adam, L. (2020). Pengetahuan penderita tuberkulosis paru terhadap kepatuhan minum obat anti tuberkulosis. Jambura Health and Sport Journal, 2(1), 12–18. https://doi.org/10.37311/jhsj.v2i1.4560

Ariyani, H. (2016). Hubungan tingkat pengetahuan dengan kepatuhan pada pengobatan penderita tuberkulosis paru di Puskesmas Pekauman Kota Banjarmasin, Kalimantan Selatan. Jurnal Pharmascience, 3(2), 23–28.

Cerni, S., Shafer, D., To, K., & Venketaraman, V. (2019). Investigating the role of everolimus in mTOR inhibition and autophagy promotion as a potential host-directed therapeutic target in mycobacterium tuberculosis infection. Journal of Clinical Medicine, 8(2), Article 232. https://doi.org/10.3390/jcm8020232

Efendi, S., Sjattar, E. L., & Syam, Y. (2022). Health counseling support medication adherence to regular pulmonary tuberculosis patients. Clinical Epidemiology and Global Health, 15, Article 101055. https://doi.org/10.1016/j.cegh.2022.101055

Fitri, L. D. (2018). Kepatuhan minum obat pada pasien tuberkulosis paru. Jurnal Ilmu Kesehatan Masyarakat, 7(1), 33–42. https://doi.org/10.33221/jikm.v7i01.50

Foster, N., Tadesse, A. W., McQuaid, C. F., Gosce, L., Abdurhman, T., Assefa, D., Bedru, A., Houben, R. M. G. J., van Kalmthout, K., Letta, T., Mohammed, Z., van Rest, J., Umeta, D. G., Weldemichael, G. T., Yazew, H., Jerene, D., Quaife, M., & Fielding, K. L. (2023). Evaluating the equity impact and cost-effectiveness of digital adherence technologies with differentiated care to support tuberculosis treatment adherence in Ethiopia: Protocol and analysis plan for the health economics component of a cluster randomised trial. Trials, 24(1), Article 289. https://doi.org/10.1186/s13063-023-07289-x

Khawbung, J. L., Nath, D., & Chakraborty, S. (2021). Drug resistant tuberculosis: A review. Comparative Immunology, Microbiology and Infectious Diseases, 74, Article 101574. https://doi.org/10.1016/j.cimid.2020.101574

Li, Y. Y., Cai, R. J., Talbot, E. A., & Wang, Y. T. (2023). Mycobacterium tuberculosis. In Molecular medical microbiology (3rd ed.). Academic Press. https://doi.org/10.1016/B978-0-12-818619-0.00010-1

Maiolini, M., Gause, S., Taylor, J., Steakin, T., Shipp, G., Lamichhane, P., Deshmukh, B., Shinde, V., Bishayee, A., & Deshmukh, R. R. (2020). The war against tuberculosis: A review of natural compounds and their derivatives. Molecules, 25(13), Article 3011. https://doi.org/10.3390/molecules25133011

Mellyana, V., Nurinda, E., & Fauzi, R. (2022). Hubungan pengetahuan terhadap tingkat kepatuhan pasien tuberkulosis paru di Puskesmas Binangun Cilacap. INPHARNMED Journal (Indonesian Pharmacy and Natural Medicine Journal), 5(2), 1–8. https://doi.org/10.21927/inpharnmed.v5i2.1884

Natarajan, A., Beena, P. M., Devnikar, A. V., & Mali, S. (2020). A systemic review on tuberculosis. Indian Journal of Tuberculosis, 67(3), 295–311. https://doi.org/10.1016/j.ijtb.2020.02.005

Ndjoubi, K. O., Sharma, R., & Hussein, A. A. (2020). The potential of natural diterpenes against tuberculosis: An updated review. Current Pharmaceutical Design, 26(24), 2826–2837. https://doi.org/10.2174/1381612826666200612163326

Ockenga, J., Fuhse, K., Chatterjee, S., Malykh, R., Rippin, H., Pirlich, M., Yedilbayev, A., Wickramasinghe, K., & Barazzoni, R. (2023). Tuberculosis and malnutrition: The European perspective. Clinical Nutrition, 42(4), 508–514. https://doi.org/10.1016/j.clnu.2023.01.016

Putra Siswanto, I., Yanwirasti, & Usman, E. (2015). Hubungan pengetahuan dan dukungan keluarga dengan kepatuhan minum obat anti tuberkulosis di Puskesmas Andalas Kota Padang. Jurnal Kesehatan Andalas, 4(3), 884–890. https://doi.org/10.25077/jka.v4i3.354

Rosadi, D. (2020). Faktor-faktor yang berhubungan dengan kepatuhan pasien tuberkulosis paru terhadap obat anti tuberkulosis. Jurnal Berkala Kesehatan, 6(2), 80–87. https://doi.org/10.20527/jbk.v6i2.9452

World Health Organization. (2018). Global tuberculosis report 2018. World Health Organization.

Young, C., Walzl, G., & Du Plessis, N. (2020). Therapeutic host-directed strategies to improve outcome in tuberculosis. Mucosal Immunology, 13(2), 190–204. https://doi.org/10.1038/s41385-019-0226-5

Downloads

Published

2025-09-08